Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-23T12:25:05.868Z Has data issue: false hasContentIssue false
  • English
  • Français

Health economics in mental health. 2: Economic evaluation

Published online by Cambridge University Press:  02 January 2018

Neil Craig  and
Cameron Stark
Neil Craig*
Affiliation:
Health Economist, Department of Public Health, University of Glasgow, 2 Lilybank Gardens, Glasgow G12 8RZ
Cameron Stark
Affiliation:
Consultant in Public Health Medicine, Highland Health Board, Beechwood Park, Inverness W2 3HG
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This paper is the second in a series explaining key concepts and techniques used in health economics in the context of mental health care. The paper describes the different types of economic analysis and the circumstances in which they should be used. It explains key aspects of the methods used in economic evaluation to measure costs and benefits. The purpose of the paper is not to enable clinicians to undertake economic analysis, but to familiarise them with the methods used in economic evaluation and to enable them to assess the rigour and results of published studies.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 21 , Issue 11 , November 1997 , pp. 687 - 691
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

Addington, D. E., Jones, B., Bloom, D., et al (1993) Reduction of hospital days in chronic schizophrenic patients treated with risperidone: A retrospective study. Clinical Therapeutics, 15, 917–926.Google Scholar
Burns, T., Raftery, J., Beadsmoore, A., et al (1993) A controlled trial of home-based acute psychiatric services. II: Treatment patterns and costs. British Journal of Psychiatry, 163, 55–61.Google Scholar
Carpenter, W. T., Conley, R. R., Buchanan, R. W., et al (1995) Patient response and resource management. Another view of clozapine treatment of schizophrenia. American Journal of Psychiatry, 152, 827–832.Google Scholar
Carr-Hill, R. & Morris, J. (1991) Current practice in obtaining the ‘Q’ in QALYs: a cautionary note. British Medical Journal, 303, 699–701.Google Scholar
Davies, L. M. & Drummond, M. F. (1993) Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the UK. British Journal of Psychiatry, 162, 38–42.Google Scholar
Donaldson, C., Atkinson, K., Bond, J., et al (1988) Should QALYs be programme-specific? Journal of Health Economics, 7, 239–257.Google Scholar
EuroQoL Group (1990) EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208.Google Scholar
Goldberg, D. (1995) Cost-effectiveness studies in the valuation of mental health services in the community: current knowledge and problems. International Clinical Psychopharmacology, 9 (suppl. 5), 29–34.Google Scholar
Hallam, A., Beecham, J., Knapp, M., et al (1994) The costs of accommodation and care: Community provision for former long-stay psychiatric hospital patients. European Archives of Psychiatry and Clinical Neurosciences, 243, 304–310.CrossRefGoogle ScholarPubMed
Kavanagh, S. (1993) Elderly people with cognitive impairment: Costing possible changes in the balance of care. Health and Social Care in the Community, 1, 69–80.Google Scholar
Kind, P. & Dolan, P. (1995) The effect of past and present illness experience on the valuation of health states. Medical Care, 33, AS255–AS263.Google Scholar
Knapp, M., Beecham, J., Anderson, J., et al (1990) The TAPS Project. 3: Predicting the community costs of closing psychiatric hospitals. British Journal of Psychiatry, 157, 661–670.Google Scholar
Knapp, M., Beecham, J., Koutsogeorgopoulou, V., et al (1994a) Service use and costs of home-based versus hospital-based care for people with serious mental illness. British Journal of Psychiatry, 165, 195–203.Google Scholar
Knapp, M., Cambridge, P., Thomason, C., et al (1994b) Residential care as an alternative to long-stay hospital: a cost-effectiveness evaluation of two pilot projects. International Journal of Geriatric Psychiatry, 9, 297–304.Google Scholar
Meltzer, H. Y., Cola, P., Way, L., et al (1993) Cost-effectiveness of clozapine in neuroleptic-resistant schizophrenia. American Journal of Psychiatry, 150, 1630–1638.Google Scholar
Mooney, G. (1989) QALYs: Are they enough? A health economist's perspective. Journal of Medical Ethics, 15, 148–152.Google Scholar
Rawles, J. M. (1989) Castigating QALYs. Journal of Medical Ethics, 15, 143–147.Google Scholar
Reid, W. H., Mason, M. & Toprac, M. (1994) Savings in hospital bed-days related to treatment with clozapine. Hospital and Community Psychiatry, 45, 261–263.Google Scholar
Rosenheck, R., Neale, M. & Frisman, L. (1995) Issues in estimating the cost of innovative mental health programs, Psychiatric Quarterly, 66, 9–31.Google Scholar
Wilkinson, G., Williams, B., Krekorian, H., et al (1992) QALYs in mental health: a case study. Psychological Medicine, 22, 725–731.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.